Literature DB >> 12495373

Autism, an extreme challenge to integrative medicine. Part 2: medical management.

Parris M Kidd.   

Abstract

Autism and allied autistic spectrum disorders (ASD) present myriad behavioral, clinical, and biochemical abnormalities. Parental participation, advanced testing protocols, and eclectic treatment strategies have driven progress toward cure. Behavioral modification and structured education are beneficial but insufficient. Dietary restrictions, including removal of milk and other casein dairy products, wheat and other gluten sources, sugar, chocolate, preservatives, and food coloring are beneficial and prerequisite to benefit from other interventions. Individualized IgG or IgE testing can identify other troublesome foods but not non-immune mediated food sensitivities. Gastrointestinal improvement rests on controlling Candida and other parasites, and using probiotic bacteria and nutrients to correct dysbiosis and decrease gut permeability. Detoxification of mercury and other heavy metals by DMSA/DMPS chelation can have marked benefit. Documented sulfoxidation-sulfation inadequacies call for sulfur-sulfhydryl repletion and other liver p450 support. Many nutrient supplements are beneficial and well tolerated, including dimethylglycine (DMG) and a combination of pyridoxine (vitamin B6) and magnesium, both of which benefit roughly half of ASD cases. Vitamins A, B3, C, and folic acid; the minerals calcium and zinc; cod liver oil; and digestive enzymes, all offer benefit. Secretin, a triggering factor for digestion, is presently under investigation. Immune therapies (pentoxifyllin, intravenous immunoglobulin, transfer factor, and colostrum) benefit selected cases. Long-chain omega-3 fatty acids offer great promise. Current pharmaceuticals fail to benefit the primary symptoms and can have marked adverse effects. Individualized, in-depth clinical and laboratory assessments and integrative parent-physician-scientist cooperation are the keys to successful ASD management.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12495373

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  18 in total

Review 1.  Gluten- and casein-free diets for autistic spectrum disorder.

Authors:  C Millward; M Ferriter; S Calver; G Connell-Jones
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

2.  Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains.

Authors:  Wynne Q Zhang; Corey M Smolik; Priscilla A Barba-Escobedo; Monica Gamez; Jesus J Sanchez; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

3.  Dysbiosis of Gut Fungal Microbiota in Children with Autism Spectrum Disorders.

Authors:  Rong Zou; Yuezhu Wang; Mengmeng Duan; Min Guo; Qiang Zhang; Huajun Zheng
Journal:  J Autism Dev Disord       Date:  2021-01

4.  A preliminary study on nutritional status and intake in Chinese children with autism.

Authors:  Wei Xia; Yanjuan Zhou; Caihong Sun; Jia Wang; Lijie Wu
Journal:  Eur J Pediatr       Date:  2010-04-27       Impact factor: 3.183

Review 5.  The role of nutraceuticals in the management of autism.

Authors:  Abdulrahman S Alanazi
Journal:  Saudi Pharm J       Date:  2012-10-23       Impact factor: 4.330

6.  An exploration of Glo-3A antibody levels in children at increased risk for type 1 diabetes mellitus.

Authors:  M Simpson; M Mojibian; K Barriga; F W Scott; A Fasano; M Rewers; J M Norris
Journal:  Pediatr Diabetes       Date:  2009-07-20       Impact factor: 4.866

7.  Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders.

Authors:  Maria Rosaria Iovene; Francesca Bombace; Roberta Maresca; Anna Sapone; Patrizia Iardino; Annarita Picardi; Rosa Marotta; Chiara Schiraldi; Dario Siniscalco; Nicola Serra; Laura de Magistris; Carmela Bravaccio
Journal:  Mycopathologia       Date:  2016-09-21       Impact factor: 2.574

8.  Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory.

Authors:  K Dettmer; D Hanna; P Whetstone; R Hansen; B D Hammock
Journal:  Anal Bioanal Chem       Date:  2007-05-23       Impact factor: 4.142

9.  Dysautonomia in autism spectrum disorder: case reports of a family with review of the literature.

Authors:  Derrick Lonsdale; Raymond J Shamberger; Mark E Obrenovich
Journal:  Autism Res Treat       Date:  2011-05-31

10.  Use of autism-related services by families and children.

Authors:  Kathleen C Thomas; Joseph P Morrissey; Carolyn McLaurin
Journal:  J Autism Dev Disord       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.